Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | EBP | Q15125 | 4/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.53 |
| ▸ | MMP1 | P03956 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | MCHR1 | Q99705 | 5/20 | 0.48 |
| ▸ | ESR1 | P03372 | 4/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL330094 | 0.88 | SIGMAR1 (0.67) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| SCHEMBL16910242 | 0.81 | SIGMAR1 (0.69) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| SCHEMBL3294808 | 0.80 | CYP2D6 (0.54) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| Citric Acid SCHEMBL17164694 | 0.79 | KDM4E (0.59) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| SCHEMBL8707174 | 0.78 | EBP (0.56) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| SCHEMBL7753432 | 0.75 | SIGMAR1 (0.79) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| SCHEMBL6769894 | 0.75 | CYP2D6 (0.48) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| SCHEMBL4310502 | 0.74 | EBP (0.81) | CYP2D6HTTCYP1A2LTA4HCYP2C9 | |
| SCHEMBL1379752 | 0.74 | LTA4H (0.57) | HTTLTA4HSIGMAR1MMP1MMP13 | |
| SCHEMBL10356744 | 0.74 | CYP2D6 (0.58) | CYP2D6HTTCYP1A2LTA4HCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3515424-A1 | ANTIESTROGENS AND/OR AROMATASE INHIBITORS FOR USE IN TREATING OBESITY AND RELATED SYMPTOMS | Repros Therapeutics Inc. (US) | 2019-07-31 | — | — | EP | disclosed |
| WO-2018058032-A1 | ANTIESTROGENS AND/OR AROMATASE INHIBITORS FOR USE IN TREATING OBESITY AND RELATED SYMPTOMS | REPROS THERAPEUTICS INC. (US) | 2018-03-29 | — | — | WO | disclosed |
| EP-2914294-A1 | TRANS-CLOMIPHENE FOR USE IN CANCER THERAPY | Repros Therapeutics Inc. (US) | 2015-09-09 | — | — | EP | disclosed |
| EP-2819676-A1 | COMBINATION THERAPY FOR TREATING ANDROGEN DEFICIENCY | Repros Therapeutics Inc. (US) | 2015-01-07 | — | — | EP | disclosed |
| WO-2014070523-A1 | TRANS-CLOMIPHENE FOR USE IN CANCER THERAPY | REPROS THERAPEUTICS INC. (US) | 2014-05-08 | — | — | WO | disclosed |
| WO-2013130832-A1 | COMBINATION THERAPY FOR TREATING ANDROGEN DEFICIENCY | REPROS THERAPEUTICS INC. (US) | 2013-09-06 | — | — | WO | disclosed |
| EP-2211848-A1 | TRANS-CLOMIPHENE FOR METABOLIC SYNDROME | Repros Therapeutics Inc. (US) | 2010-08-04 | — | — | EP | disclosed |
| WO-2010054248-A1 | TRANS-CLOMIPHENE FOR METABOLIC SYNDROME AND DIABETES MELLITUS TYPE 2 | REPROS THERAPEUTICS INC. (US) | 2010-05-14 | — | — | WO | disclosed |
| WO-2009051908-A1 | TRANS-CLOMIPHENE FOR METABOLIC SYNDROME | REPROS THERAPEUTICS INC. (US) | 2009-04-23 | — | — | WO | disclosed |